FDA Issues FY23 Drug Safety Priorities ReportÂ
In February 2024, FDA’s Center for Drug Evaluation and Research (CDER) published its ninth yearly report describing key safety programs and activities, and illustrating the depth and versatility of drug…
Read MoreMeet AAHP’s Newest Board Member
Brenda Van Goethem, Director of Regulatory Compliance & Change Management for Nature’s Way, is the newest member of AAHP’s Board of Directors. Elections for two-year terms were held at the…
Read MoreFDA Warnings: Mistakes to Avoid
What Is Your Company Paying Attention To? And what is the FDA paying attention to? In a recent 30-day period, FDA sent 33 warning letters addressing all product categories under…
Read MoreThe Homeopathic Pharmacopoeia of the United States
By Mark Land, MS, RAC-US, AAHP President The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and many…
Read MoreThe HPCUS Response to Current Challenges
By William Shevin, MD, DHt, HPCUS President After one of my patients with complex problems that defied even expert management by conventional means was dramatically helped by homeopathy, I saw…
Read MoreRemote Regulatory AssessmentsÂ
Remote Regulatory Assessments By Alvin J. Lorman, AAHP Counsel COVID-19 changed the way most people and most organizations operated. Like working from home, some of those changes have lasted beyond…
Read MoreImproving Your Environmental ReputationÂ
By Alissa Gould, Boiron USA, Director of Communications It’s easy to argue that homeopathic manufacturing companies are ecological. Afterall, a small amount of resources from Mother Earth, most of which…
Read MoreSustainable Packaging: Considerations for Homeopathic Manufacturers Â
As our society places increasing emphasis on sustainability and environmental conservation, packaging has become a focal point for consumers, regulators, and brands alike. The homeopathic drug products industry is no…
Read MoreHomeopathic Medicines: Good for the Body and Good for the EnvironmentÂ
By Mark Land, MS, RAC-US, AAHP President The impacts of industrialism have been under attack for many decades. By some measures, previous generations of American consumers have pushed the devastating…
Read MoreFDA Guidance Document Development ProcessÂ
By Alvin J. Lorman, AAHP Counsel The Food and Drug Administration (FDA) is seeking public comment on a draft “Report and Plan on Best Practices for Guidance.” Guidance documents, rather…
Read More